Document is current
Any future updates will be listed below
-
Authors
Hinterndorfer, Matthias https://orcid.org/0000-0003-2435-4690
Spiteri, Valentina A.
Ciulli, Alessio https://orcid.org/0000-0002-8654-1670
Winter, Georg E. https://orcid.org/0000-0001-6606-1437
- License Information
-
More Information
Article History
Accepted: 21 March 2025
First Online: 25 April 2025
Competing interests
: A.C. is a scientific founder and shareholder of Amphista Therapeutics, a company that is developing TPD therapeutic platforms. A.C. is on the scientific advisory board of ProtOS. G.E.W. is scientific founder and shareholder of Proxygen and Solgate Therapeutics and shareholder of Cellgate Therapeutics. G.E.W. is on the Scientific Advisory Board of Proxygen and Nexo Therapeutics. The Winter laboratory has received research funding from Pfizer. The other authors declare no competing interests.
